Skip to main content
. 2024 Mar 20;15:2493. doi: 10.1038/s41467-024-46840-5

Fig. 5. Antihistamine design of H4R.

Fig. 5

a A schematic diagram of the antihistamine design of H4R, utilizing key information of E182/ligand interaction. b VUF5202 exhibits inverse agonist activity. Data are presented as mean values ± SEM.; n = 3 independent experiments for the binding assay (both Clobenpropit and VUF5202), n = 6 for Clobenpropit BRET assay, and n = 3 for VUF5202 BRET assay. Source data are provided as a Source Data file.